Alerts will be sent to your verified email
Verify EmailEVOQ
|
EVOQ Remedies
|
Dipna Pharma.
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
21.9 % | 16.1 % | 12.26 % |
|
5yr average Equity Multiplier
|
3.25 | 14.87 | 2.68 |
|
5yr Average Asset Turnover Ratio
|
0.54 | 1.35 | 0.93 |
|
5yr Avg Net Profit Margin
|
6.7 % | 0.81 % | 5.75 % |
|
Price to Book
|
0.0 | 0.32 | 0.68 |
|
P/E
|
0.0 | 19.4 | 4.87 |
|
5yr Avg Cash Conversion Cycle
|
149.18 Days | -33.62 Days | 138.58 Days |
|
Inventory Days
|
70.89 Days | 62.45 Days | 96.42 Days |
|
Days Receivable
|
160.81 Days | 112.8 Days | 135.23 Days |
|
Days Payable
|
163.4 Days | 139.84 Days | 103.44 Days |
|
5yr Average Interest Coverage Ratio
|
2683.3 | 2.01 | 4.03 |
|
5yr Avg ROCE
|
29.29 % | 12.33 % | 17.72 % |
|
5yr Avg Operating Profit Margin
|
-11.9 % | 2.41 % | 10.31 % |
|
5 yr average Debt to Equity
|
0.18 | 5.84 | 0.9 |
|
5yr CAGR Net Profit
|
-34.02 % | 117.34 % | 50.43 % |
|
5yr Average Return on Assets
|
3.64 % | 1.21 % | 5.01 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.02 % | 9.13 % | 67.47 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-73.51 % | -57.43 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
EVOQ Remedies
|
Dipna Pharma.
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|